4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-002439
Chief Business Officer sold 11,000 shares at $50.50 ($555,552)
- Chief Business Officer acquired 14,037 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Robb Gary Charles Chief Business Officer | 2025-01-02 | Option exercise 10b5-1 | +11,000 | $3.29 | $36,190 | 31,119 | D |
| Robb Gary Charles Chief Business Officer | 2025-01-02 | Sale 10b5-1 | −11,000 | $50.50 | $555,552 | 20,119 | D |
| Robb Gary Charles Chief Business Officer | 2025-01-03 | Option exercise 10b5-1 | +3,037 | $3.29 | $9,992 | 23,156 | D |
| Derivatives | |||||||
| Robb Gary Charles Chief Business Officer | 2025-01-02 | Option exercise · Stock option (right to buy) 10b5-1 | −11,000 | 3,037 | D | ||
| Robb Gary Charles Chief Business Officer | 2025-01-03 | Option exercise · Stock option (right to buy) 10b5-1 | −3,037 | 0 | D | ||
| Open-market sales · 11,000 sh · avg $50.50 · $555,552 | |||||||
Loading xslF345X05/ownership.xml…